The Net Margin of NeuBase Therapeutics Inc (NBSE) is -3950.00%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2022-12-31 | -3950.00% |